SIREN : 331915876
COMPAGNIE GENERALE DE SANTE is a French company founded 41 years ago, specialized in the sector Activités des sièges sociaux. Based in PARIS (75017), this company of category GE shows in 2025 a revenue of 38.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 38 051 290 € | 37 465 766 € | 31 978 096 € | 25 747 483 € | 24 490 304 € | 23 055 040 € | 18 946 166 € |
| Net income | -66 647 744 € | -1 677 425 € | 222 124 538 € | -304 796 645 € | 56 903 871 € | 139 479 567 € | 100 906 909 € |
| EBITDA | -19 005 046 € | -14 954 890 € | -14 281 442 € | -17 902 537 € | -21 734 058 € | -17 855 450 € | -11 497 240 € |
| Net margin | -175.2% | -4.5% | 694.6% | -1183.8% | 232.4% | 605.0% | 532.6% |
In 2025, COMPAGNIE GENERALE DE SANTE achieves revenue of 38.1 M€. Over the period 2017-2025, the company shows strong growth with a CAGR (compound annual growth rate) of +9.1%. Vs 2024: +2%. After deducting consumption (0 €), gross margin stands at 38.1 M€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -19.0 M€, representing -49.9% of revenue. Warning negative scissor effect: despite revenue change (+2%), EBITDA varies by -27%, reducing margin by 10.0 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -66.6 M€ (-175.2% of revenue), which will impact equity.
38 051 290 €
38 051 290 €
-19 005 046 €
-2 253 340 €
-66 647 744 €
-49.9%
The debt ratio (= Financial debt / Equity x 100) stands at 156%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 29%. The balance between equity and debt is satisfactory.
155.793%
28.928%
-117.303%
-21.986
24.5%
In 2025, the debt ratio of COMPAGNIE GENERALE DE SANTE (155.79) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2025, the financial autonomy of COMPAGNIE GENERALE DE SANTE (28.9%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2025, the repayment capacity of COMPAGNIE GENERALE DE SANTE (-21.99) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 87.84. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
87.836
-2590.864
In 2025, the liquidity ratio of COMPAGNIE GENERALE DE SANTE (87.84) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
In 2025, the interest coverage of COMPAGNIE GENERALE DE SANTE (-2590.9x) ranks in the bottom 25% of the sector. This ratio indicates how many times operating income covers interest expenses. Low coverage may indicate fragility to rate or income variations.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 92 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 24 days. The gap of 68 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. WCR is negative (-1548 days): operations structurally generate cash. Notable WCR improvement over the period (-169%), freeing up cash.
-163 608 371 €
92 j
24 j
0 j
-1548 j
Based on 54 transactions of similar company sales
in 2025,
the value of COMPAGNIE GENERALE DE SANTE is estimated at
24 003 730 €
(range 9 983 686€ - 27 131 818€).
The price/revenue ratio is 0.63x
(in line with sector norms).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 54 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare COMPAGNIE GENERALE DE SANTE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sièges sociaux
The revenue of COMPAGNIE GENERALE DE SANTE in 2025 is 38.1 M€.
COMPAGNIE GENERALE DE SANTE recorded a net loss in 2025.
The headquarters of COMPAGNIE GENERALE DE SANTE is located in PARIS (75017), in the department Paris.
The tax return of COMPAGNIE GENERALE DE SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
COMPAGNIE GENERALE DE SANTE operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.